You are here: Industry Insights > therapy

News List

FDA awards breakthrough status to La Jolla’s malaria therapy europeanpharmaceuticalreview
April 26, 2019
FDA awards breakthrough status to La Jolla’s malaria therapy.
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease europeanpharmaceuticalreview
April 25, 2019
Mount Sinai shows the potential link between Parkinson’s disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson’s…
RNA-based therapy cures lung cancer europeanpharmaceuticalreview
April 25, 2019
By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice…
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy b3cnewswire
April 23, 2019
Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy.
Puma licences breast cancer therapy to Pierre Fabre in Europe pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
Sangamo announces promising early results for haemophilia A gene therapy pharmaceutical-technology
April 23, 2019
Sangamo announces promising early results for haemophilia A gene therapy.
AskBio secures $235m investment to accelerate growth pharmaceutical-technology
April 23, 2019
Gene therapy company Asklepios BioPharmaceutical (AskBio) has received an investment of $225m from TPG Capital and Vida Ventures to accelerate its long-term growth.
Catalent to buy gene therapy manufacturer Paragon for $1.2bn pharmaceutical-technology
April 23, 2019
Catalent to buy gene therapy manufacturer Paragon for $1.2bn...
Successful kidney transplants from hepatitis C infected individuals europeanpharmaceuticalreview
April 22, 2019
Transplantation followed by antiviral therapy cured hepatitis C in 100 percent of patients receiving kidneys from infected donors…
Bacterial therapy shows early promise in patients with advanced solid tumours europeanpharmaceuticalreview
April 19, 2019
Researchers have presented results of a Phase I clinical trial using bacterial Clostridium novyi-NT spores to target advanced solid tumours…

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page